Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Expenditures: 2014-2024

Historic Capital Expenditures for Editas Medicine (EDIT) over the last 11 years, with Dec 2024 value amounting to $8.8 million.

  • Editas Medicine's Capital Expenditures fell 85.18% to $433,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 58.22%. This contributed to the annual value of $8.8 million for FY2024, which is 87.03% up from last year.
  • As of FY2024, Editas Medicine's Capital Expenditures stood at $8.8 million, which was up 87.03% from $4.7 million recorded in FY2023.
  • Editas Medicine's 5-year Capital Expenditures high stood at $8.8 million for FY2024, and its period low was $4.1 million during FY2022.
  • Moreover, its 3-year median value for Capital Expenditures was $4.7 million (2023), whereas its average is $5.9 million.
  • Per our database at Business Quant, Editas Medicine's Capital Expenditures slumped by 48.38% in 2022 and then skyrocketed by 87.03% in 2024.
  • Yearly analysis of 5 years shows Editas Medicine's Capital Expenditures stood at $7.2 million in 2020, then grew by 11.38% to $8.0 million in 2021, then slumped by 48.38% to $4.1 million in 2022, then increased by 14.59% to $4.7 million in 2023, then soared by 87.03% to $8.8 million in 2024.